Summary of HSS and LSI during the LIST. by Dominic Michael Rasp (19959412)

Subjects:

S2 Raw data - by Dominic Michael Rasp (19959412)

Subjects:

Set-up of the optimized 90:20 Isometric Posterior Chain Test. by Dominic Michael Rasp (19959412)

Subjects:

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

“…Among them, W₃BipY₈-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W₃BipY₈ but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W₃BipY₈. …”

Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

Subjects:

PRISMA flowchart of the article selection process. by Renáta Kiss-Miki (20760127)

Subjects:

List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the mean difference of global IQ level among pediatric brain cancer patients treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the ratio of odds of hypothyroidism (=event) among pediatric brain cancer patients treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the odds of 5-year overall-survival rate among children with brain tumors treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Data_table_with_all_identified_articles_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Data_extraction_table_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the ratio of odds of grade 3 anemia (=event) among pediatric patients with brain tumors treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Assignment of interventions to community health centers (CHCs) in districts. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Estimated effects of the intervention packages on the incidence of NCDs metabolic risk factors. by Mehran Asadi-Aliabadi (8383110)

Subjects:

The difference in NCDs metabolic risk factors’ prevalence between the two surveys. by Mehran Asadi-Aliabadi (8383110)

Subjects:

CONSORT flow diagram. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Demographic and economic characteristics of participants (frequencies and percentages). by Mehran Asadi-Aliabadi (8383110)

Subjects:

Districts of intervention and no intervention in IRPONT study. by Mehran Asadi-Aliabadi (8383110)

Subjects:

SIM and SIMA detection in real samples. by Ewa Paszkowska (21246702)

Subjects: